Literature DB >> 115106

A potent new inhibitor of platelet aggregation and experimental thrombosis, anagrelide (BL-4162A).

J S Fleming, J P Buyniski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 115106     DOI: 10.1016/0049-3848(79)90145-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  6 in total

1.  Comparison of the biological activities of anagrelide and its major metabolites in haematopoietic cell cultures.

Authors:  Guosu Wang; Richard Franklin; Ying Hong; Jorge D Erusalimsky
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

2.  Inhibition of human primary megakaryocyte differentiation by anagrelide: a gene expression profiling analysis.

Authors:  Kazuki Sakurai; Tohru Fujiwara; Shin Hasegawa; Yoko Okitsu; Noriko Fukuhara; Yasushi Onishi; Minami Yamada-Fujiwara; Ryo Ichinohasama; Hideo Harigae
Journal:  Int J Hematol       Date:  2016-04-15       Impact factor: 2.490

3.  Effect of encainide, ODE, MODE, and flecainide on ADP/5-HT induced platelet aggregation and in the anesthetized dog coronary artery stenosis-occlusion model of intravascular thrombosis.

Authors:  J S Fleming; J O Buchanan; F D Yocca; L G Iben; M J Antonaccio
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

Review 4.  Anagrelide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of thrombocythaemia.

Authors:  C M Spencer; R N Brogden
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

5.  A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia - the TEAM-ET 2·0 trial.

Authors:  Heinz Gisslinger; Veronika Buxhofer-Ausch; Juri Hodisch; Atanas Radinoff; Elena Karyagina; Slawomira Kyrcz-Krzemień; Kudrat Abdulkadyrov; Rolandas Gerbutavicius; Anait Melikyan; Sonja Burgstaller; Marek Hus; Janusz Kłoczko; Vera Yablokova; Nikolay Tzvetkov; Malgorzata Całbecka; Tatyana Shneyder; Krzysztof Warzocha; Mindaugas Jurgutis; Kamil Kaplanov; Bernd Jilma; Christian Schoergenhofer; Christoph Klade
Journal:  Br J Haematol       Date:  2019-03-28       Impact factor: 6.998

6.  Anagrelide Modulates Proplatelet Formation Resulting in Decreased Number and Increased Size of Platelets.

Authors:  Naohiro Miyashita; Masahiro Onozawa; Shota Yokoyama; Daisuke Hidaka; Koji Hayasaka; Shinji Kunishima; Takanori Teshima
Journal:  Hemasphere       Date:  2019-08-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.